Antiproliferative effect of c-myc antisense phosphorothioate oligodeoxynucleotides in malignant glioma cells

Neurosurgery

Volumn 41, Issue 4, 1997, Pages 908-915

  Broaddus, William C ^a,b   Chen, Zhi J ^a   Prabhu, Sujit S ^a   Loudon, William G ^a   Gillies, George T ^a   Phillips, Linda L ^a   Fillmore, Helen ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Research Service   (United States)

Author keywords

Antisense; C myc; Glioma; Oligodeoxynucleotide; Oncogene; Proliferation

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; MESSENGER RNA; ONCOPROTEIN; PHOSPHOROTHIOIC ACID DERIVATIVE;

ANIMAL CELL; ARTICLE; CANCER INHIBITION; CELL PROLIFERATION; CONTROLLED STUDY; GENE EXPRESSION; GENE THERAPY; GLIOMA; NONHUMAN; ONCOGENE C MYC; PRIORITY JOURNAL; PROTO ONCOGENE; RAT;

ANIMALS; BLOTTING, WESTERN; BRAIN NEOPLASMS; CELL DIVISION; CELL LINE, TRANSFORMED; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOBLASTOMA; HUMANS; OLIGONUCLEOTIDES, ANTISENSE; PROTO-ONCOGENE PROTEINS C-MYC; RATS; RATS, INBRED F344; THIONUCLEOTIDES; TUMOR CELLS, CULTURED;

EID: 0030816506     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006123-199710000-00027     Document Type: Article

References (29)

1. Alitalo K, Koskinen P, Makela TP, Saksela K, Sistonen L, Winqvist R: Myc oncogenes: Activation and amplification. Biochim Biophys Acta 907:1-32, 1987.
2. Alley MC, Scudiero DA, Monks A, Hursey ML, Czerwinski MJ, Fine DL, Abbott BJ, Mayo JG, Shoemaker RH, Boyd MR: Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay. Cancer Res 48:589-601, 1988.
3. Biro S, Fu YM, Yu ZX, Epstein SE: Inhibitory effects of antisense oligodeoxynucleotides targeting c-Myc mRNA on smooth muscle cell proliferation and migration. Proc Natl Acad Sci U S A 90: 654-658, 1993.
4. Burgess TL, Fisher EF, Ross SL, Bready JV, Qian YX, Bayewitch LA, Cohen AM, Herrera CJ, Hu SS, Kramer TB: The antiproliferative activity of c-myb and c-Myc antisense oligonucleotides in smooth muscle cells is caused by a nonantisense mechanism. Proc Natl Acad Sci U S A 92:4051-4055, 1995.
5. Chattopadhyay P, Banerjee M, Sarkar C, Mathur M, Mohapatra AK, Sinha S: infrequent alteration of the c-myc gene in human glial tumours associated with increased numbers of c-myc positive cells. Oncogene 11:2711-2714, 1995.
6. Chavany C, Connell Y, Neckers L: Contribution of sequence and phosphorothioate content to inhibition of cell growth and adhesion caused by c-myc antisense oligomers. Mol Pharmacol 48:738-746, 1995.
7. Crooke RM: In vitro toxicology and pharmacokinetics of antisense oligonucleotides. Anticancer Drug Des 6:609-646, 1991.
8. Ebbecke M, Unterberg C, Buchwald A, Stohr S, Wiegand V: Antiproliferative effects of a c-Myc antisense oligonucleotide on human arterial smooth muscle cells. Basic Res Cardiol 87:585-591, 1992.
9. Engelhard HH III, Butler AB IV, Bauer KD: Quantification of the c-myc oncoprotein in human glioblastoma cells and tumor tissue. J Neurosurg 71:224-232, 1989.
10. Evan GI, Littlewood TD: The role of c-Myc in cell growth. Curr Opin Genet Dev 3:44-49, 1993.
11. Hertl M, Neckers LM, Katz SI: Inhibition of interferon-gamma-induced intercellular adhesion molecule-1 expression on human keratinocytes by phosphorothioate antisense oligodeoxynucleotides is the consequence of antisense-specific and antisense non-specific effects. J Invest Dermatol 104:813-818, 1995.
12. Hesketh R: MYC, in The Oncogene Handbook. New York, Academic Press, 1994, pp 314-352.
13. Hirvonen HE, Salonen R, Sandberg MM, Vuorio E, Vastrik I, Kotilainen E, Kalimo H: Differential expression of myc, max and RB1 genes in human gliomas and glioma cell lines. Br J Cancer 69:16-25, 1994.
14. LaRocca RV, Rosenblum M, Westermark B, Israel MA: Patterns of proto-oncogene expression in human glioma cell lines. J Neurosci Res 24:97-106, 1989.
15. Mahaley MS, Gentry RE, Bigner DD: Immunobiology of primary intracranial tumors: Part 2 - The evaluation of chemotherapy and immunotherapy protocols using the avian sarcoma virus glioma model. J Neurosurg 47:35-43, 1977.
16. Packham G, Cleveland JL: c-Myc and apoptosis. Biochim Biophys Acta 1242:11-28, 1995.
17. Prabhu SS, Broaddus WC, Gillies GT, Neal J: Distribution and stability of antisense phosphorothioate oligonucleotide in a rodent brain following direct intraparenchymal high-flow microinfusion. Proceedings of the American Association for Cancer Research, Eighty-Seventh Annual Meeting. 37:302, 1996 (abstr).
18. Prins J, De Vries EG, Mulder NH: Antisense of oligonucleotides and the inhibition of oncogene expression. Clin Oncol (R Coll Radiol) 5:245-252, 1993.
19. Shaw JP, Kent K, Bird J, Fishback J, Froehler B: Modified deoxyoligonucleotides stable to exonuclease degradation in serum. Nucleic Acids Res 19:747-750, 1991.
20. Shindo H, Tani E, Kochi N, Kaba K, Matsumoto T, Miyaji K, Yamamoto Y, Furuyama J: Interspecies comparison of c-myc gene in human and rat glioma cell lines. Acta Neuropathol (Berl) 81:382-387, 1991.
21. Shindo H, Tani E, Matsumoto T, Hashimoto T, Furuyama J: Stabilization of c-myc protein in human glioma cells. Acta Neuropathol (Berl) 86:345-352, 1993.
22. Simons M, Rosenberg RD: Antisense nonmuscle myosin heavy chain and c-myb oligonucleotides suppress smooth muscle cell proliferation in vitro. Circ Res 70:835-843, 1992.
23. Temsamani J, Kubert M, Tang J, Padmapriya A, Agrawal S: Cellular uptake of oligodeoxynucleotide phosphorothioates and their analogs. Antisense Res Dev 4:35-42, 1994.
24. Trent J, Meltzer P, Rosenblum M, Harsh G, Kinzler K, Mashal R, Feinberg A, Vogelstein B: Evidence for rearrangement, amplification, and expression of c-myc in a human glioblastoma. Proc Natl Acad Sci U S A 83:470-473, 1986.
25. Wagner RW: Gene inhibition using antisense oligodeoxynucleotides. Nature 372:333-335, 1994.
26. Watson PH, Pon RT, Shiu RP: Inhibition of c-Myc expression by phosphorothioate antisense oligonucleotide identifies a critical role for c-Myc in the growth of human breast cancer. Cancer Res 51:3996-4000, 1991.
27. Wilfong RF, Bigner DD, Self DJ, Wechsler W: Brain tumor types induced by Schmidt-Ruppin strain of Rous Sarcoma Virus in inbred Fischer rats. Acta Neuropathol (Berl) 25:196-206, 1973.
28. Woolf TM: To cleave or not to cleave: Ribozymes and antisense. Antisense Res Dev 5:217-232, 1995.
29. Zon G: Brief overview of control of genetic expression by antisense oligonucleotides and in vivo applications. Mol Neurobiol 10:219-229, 1995.